2021 共识指南:极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症管理

2021-06-30 国外儿科相关医学专家组(统称) Pediatr Cardiol.2021 Jun 30.

经导管封堵早产儿动脉导管未闭(PDA)是一种安全、有效的方法,成功率为97%。本文主要针对极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症的管理提供共

中文标题:

2021 共识指南:极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症管理

英文标题:

Consensus Guidelines for the Prevention and Management of Periprocedural Complications of Transcatheter Patent Ductus Arteriosus Closure with the Amplatzer Piccolo Occluder in Extremely Low Birth Weight Infants

发布日期:

2021-06-30

简要介绍:

经导管封堵早产儿动脉导管未闭(PDA)是一种安全、有效的方法,成功率为97%。本文主要针对极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症的管理提供共识建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=封堵器行经导管动脉导管未闭封堵术围手术.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7a1a01c0021333f4, title=2021 共识指南:极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症管理, enTitle=Consensus Guidelines for the Prevention and Management of Periprocedural Complications of Transcatheter Patent Ductus Arteriosus Closure with the Amplatzer Piccolo Occluder in Extremely Low Birth Weight Infants, guiderFrom=Pediatr Cardiol.2021 Jun 30., authorId=0, author=, summary=经导管封堵早产儿动脉导管未闭(PDA)是一种安全、有效的方法,成功率为97%。本文主要针对极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症的管理提供共, cover=https://img.medsci.cn/2021722/1626958207870_2020535.jpg, journalId=0, articlesId=null, associationId=984, associationName=国外儿科相关医学专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Jun 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>经导管封堵早产儿动脉导管未闭(PDA)是一种安全、有效的方法,成功率为97%。本文主要针对极低出生体重儿应用Amplatzer Piccolo封堵器行经导管动脉导管未闭封堵术围手术期并发症的管理提供共识建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=27352, tagName=动脉导管未闭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=27352, guiderKeyword=动脉导管未闭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10682, appHits=87, showAppHits=0, pcHits=1081, showPcHits=10593, likes=0, shares=16, comments=5, approvalStatus=1, publishedTime=Thu Jul 22 22:12:09 CST 2021, publishedTimeString=2021-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 22 20:50:21 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 22:40:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=封堵器行经导管动脉导管未闭封堵术围手术.pdf)])
封堵器行经导管动脉导管未闭封堵术围手术.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1199233, encodeId=b47d119923315, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afa2142196, createdName=1301ff1fa3m, createdTime=Thu Mar 03 23:47:57 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080578, encodeId=e06310805e80b, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:06:54 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057566, encodeId=7dd6105e566bf, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:23:28 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052329, encodeId=1c18105232974, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/4a935e300e70428581ddf5c5a8934007/18969d6c1a16448dae571c9b5f52a52f.jpg, createdBy=1c6d1875332, createdName=mrcmqy, createdTime=Fri Sep 17 14:38:59 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002117, encodeId=012d100211eca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/fc368262881247c6b5a3ee2ff3552eb8/39acd95721dc46fabccc1d5eed7b3935.jpg, createdBy=eaab5449346, createdName=layforyou, createdTime=Fri Jul 23 23:20:23 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2022-03-03 1301ff1fa3m

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1199233, encodeId=b47d119923315, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afa2142196, createdName=1301ff1fa3m, createdTime=Thu Mar 03 23:47:57 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080578, encodeId=e06310805e80b, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:06:54 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057566, encodeId=7dd6105e566bf, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:23:28 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052329, encodeId=1c18105232974, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/4a935e300e70428581ddf5c5a8934007/18969d6c1a16448dae571c9b5f52a52f.jpg, createdBy=1c6d1875332, createdName=mrcmqy, createdTime=Fri Sep 17 14:38:59 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002117, encodeId=012d100211eca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/fc368262881247c6b5a3ee2ff3552eb8/39acd95721dc46fabccc1d5eed7b3935.jpg, createdBy=eaab5449346, createdName=layforyou, createdTime=Fri Jul 23 23:20:23 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-12-16 龙珠

    好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1199233, encodeId=b47d119923315, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afa2142196, createdName=1301ff1fa3m, createdTime=Thu Mar 03 23:47:57 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080578, encodeId=e06310805e80b, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:06:54 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057566, encodeId=7dd6105e566bf, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:23:28 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052329, encodeId=1c18105232974, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/4a935e300e70428581ddf5c5a8934007/18969d6c1a16448dae571c9b5f52a52f.jpg, createdBy=1c6d1875332, createdName=mrcmqy, createdTime=Fri Sep 17 14:38:59 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002117, encodeId=012d100211eca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/fc368262881247c6b5a3ee2ff3552eb8/39acd95721dc46fabccc1d5eed7b3935.jpg, createdBy=eaab5449346, createdName=layforyou, createdTime=Fri Jul 23 23:20:23 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1199233, encodeId=b47d119923315, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afa2142196, createdName=1301ff1fa3m, createdTime=Thu Mar 03 23:47:57 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080578, encodeId=e06310805e80b, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:06:54 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057566, encodeId=7dd6105e566bf, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:23:28 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052329, encodeId=1c18105232974, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/4a935e300e70428581ddf5c5a8934007/18969d6c1a16448dae571c9b5f52a52f.jpg, createdBy=1c6d1875332, createdName=mrcmqy, createdTime=Fri Sep 17 14:38:59 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002117, encodeId=012d100211eca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/fc368262881247c6b5a3ee2ff3552eb8/39acd95721dc46fabccc1d5eed7b3935.jpg, createdBy=eaab5449346, createdName=layforyou, createdTime=Fri Jul 23 23:20:23 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-09-17 mrcmqy

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1199233, encodeId=b47d119923315, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afa2142196, createdName=1301ff1fa3m, createdTime=Thu Mar 03 23:47:57 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080578, encodeId=e06310805e80b, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:06:54 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057566, encodeId=7dd6105e566bf, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:23:28 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052329, encodeId=1c18105232974, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210917/4a935e300e70428581ddf5c5a8934007/18969d6c1a16448dae571c9b5f52a52f.jpg, createdBy=1c6d1875332, createdName=mrcmqy, createdTime=Fri Sep 17 14:38:59 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002117, encodeId=012d100211eca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/fc368262881247c6b5a3ee2ff3552eb8/39acd95721dc46fabccc1d5eed7b3935.jpg, createdBy=eaab5449346, createdName=layforyou, createdTime=Fri Jul 23 23:20:23 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 layforyou

    很好

    0